Tmem199-cdg is a rare inherited condition that usually affects the liver and may also affect growth, development, or hormones. Many people with Tmem199-cdg are recognized in childhood, but the age and severity can vary. Common features can include an enlarged liver, abnormal liver blood tests, fatty liver, or cirrhosis, and some people also have low blood sugar, high blood fats, or delayed development. Not everyone will have the same experience. Tmem199-cdg is lifelong, treatment focuses on managing the problems it causes, and outlook depends on how much liver disease is present because severe scarring can become life-threatening.
How many people live with Tmem199-cdg?
TMEM199-CDG is so rare that there is no reliable published estimate for how many people are living with it worldwide or in the United States. So far, the medical literature describes only a handful of affected people and families, which means any global or U.S. number would be only a rough guess rather than a true count (Orphanet, 2024).
Overview
Tmem199-cdgSymptoms
Tmem199-cdg mainly affects the liver. Common features include an enlarged liver, high liver enzymes, fatty liver, and high cholesterol; some children also have poor growth or mild developmental delays.
Outlook and prognosis
For many living with Tmem199-cdg, the outlook depends mainly on how much the liver is affected. Some have long-term fatty liver or scarring that needs regular follow-up, while growth, learning, and daily functioning may be only mildly affected.
Causes and risk factors
Tmem199-cdg is caused by changes in both copies of the TMEM199 gene, usually inherited from each parent. It is not caused by lifestyle or environment. Other genes and day-to-day health factors may affect how severe symptoms become.
Genetic influences
Genetics are central to Tmem199-cdg because it is caused by changes in both copies of the TMEM199 gene, usually inherited from each parent. Different genetic changes can affect how severe Tmem199-cdg is and which problems appear first.
Diagnosis
Tmem199-cdg is usually diagnosed from clinical features, blood and liver tests, and imaging findings. The genetic diagnosis of Tmem199-cdg is confirmed with genetic testing, often after doctors notice a pattern of liver disease and abnormal cholesterol levels.
Treatment and drugs
Tmem199-cdg treatment focuses on liver care, nutrition, and regular monitoring of blood tests, cholesterol, and growth. Many living with Tmem199-cdg also need treatment for cirrhosis complications, and severe liver disease may lead doctors to consider a liver transplant.
Symptoms
TMEM199-CDG most often affects the liver, so day-to-day life may be shaped more by testing and follow-up than by obvious problems at first. Many people with TMEM199-CDG have abnormal liver blood tests, a fatty or enlarged liver, and sometimes slower growth or developmental differences. The early features of TMEM199-CDG are often picked up on routine testing or an ultrasound before they cause clear discomfort. Features vary from person to person and can change over time.
Many people with TMEM199-CDG have an enlarged liver, and blood tests often show ongoing liver irritation. This may not be easy to feel at first, but some may have fullness or discomfort in the upper right side of the belly.
Fat can build up inside the liver, which doctors often see on imaging. In daily life, this may cause no clear symptoms early on, but it can add to long-term liver stress.
Some people develop liver scarring over time, which is called fibrosis and can become cirrhosis if severe. When this happens, there may be swelling in the belly, easy bruising, or other signs that the liver is under strain.
Some children with TMEM199-CDG grow more slowly than expected or have trouble gaining weight. Feeding can take more time and energy, and regular growth checks are often important.
How people usually first notice Tmem199-cdg?
How TMEM199-CDG is first noticed can vary, but many families first hear that something is off after routine blood tests show ongoing liver problems, such as high liver enzymes, an enlarged liver, or fatty liver changes in infancy, childhood, or sometimes later. Some children also have slower growth or mild developmental differences, but for many living with TMEM199-CDG the liver findings are what bring them to medical attention first. Because the early signs can look like more common liver conditions, the first signs of TMEM199-CDG are often only fully understood after doctors do more specialized metabolic and genetic testing.
Types of Tmem199-cdg
No distinct types of Tmem199-CDG are widely recognized.
Can I slow down the onset of symptoms?
No, at this time there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in TMEM199-CDG, because it is a rare inherited condition and the timing of symptoms is mostly driven by the gene change itself. Healthy daily habits still matter for overall well-being, but they have not been shown to prevent this condition or push back when it begins; what they can do is support general health while research continues. Regular follow-up with doctors can help find liver, growth, or hormone problems early and treat them sooner, which may improve day-to-day health even though it does not stop the condition from developing.
What genetics can tell you about symptoms
In TMEM199-CDG, genetics can confirm the diagnosis and may give some clues about the pattern of symptoms, but it usually cannot predict every detail for one individual. People with different TMEM199 gene changes can share a similar core picture, especially liver-related problems that often begin in childhood, while the timing and severity of issues such as growth, movement, learning, or hormone-related problems can vary from one person to another. Because this condition is very rare, doctors do not yet have strong evidence that a specific genetic change always leads to a specific symptom pattern.
Causes and risk factors
Tmem199-cdg is caused by changes in both copies of the TMEM199 gene, which affects how cells handle certain proteins. A child usually develops Tmem199-cdg only after inheriting one changed copy from each parent, and the parents are often healthy carriers. Family history is an important risk factor, and the chance can be higher when parents are related by blood. Diet, exercise, infections, or anything a parent did do not cause Tmem199-cdg, but other health factors can affect how severe it seems. Because symptoms can vary, genetic testing can help confirm the cause and estimate the chance for other family members.
What are the most common causes or risk factors?
Tmem199-cdg is mainly caused by inherited changes in the TMEM199 gene that keep the body from making a certain protein work properly. It usually happens when a child inherits one changed copy of this gene from each parent, so the strongest risk factors are a family history of the condition or having parents who both carry the changed gene, even if they are healthy themselves. There are no known lifestyle, diet, or environmental causes for this disorder.
Environmental and biological risk factors
For TMEM199-CDG, the list of known risk factors is very short. Doctors often group risks into internal (biological) and external (environmental), but no clear pregnancy, parental-age, birth, or exposure-related risks have been firmly linked to this rare condition. Because TMEM199-CDG is so rare, research on risk factors for TMEM199-CDG is still limited, and these answers may change as more is learned.
Advanced maternal or paternal age has not been established as a risk factor for TMEM199-CDG. Studies so far have not shown a clear age-related pattern.
Maternal illness, infection, or poor nutrition during pregnancy has not been proven to raise the chance of TMEM199-CDG. Researchers have not identified a consistent pregnancy-related trigger.
Exposures such as radiation, heavy metals, or air pollution have not been clearly linked to TMEM199-CDG. No specific environmental cause has been confirmed in medical reports so far.
Prematurity, low birth weight, or delivery complications are not known to cause TMEM199-CDG. These issues can affect a baby's health in other ways, but they are not established risk factors for this condition.
Genetic risk factors
TMEM199-CDG happens when someone inherits harmful changes in both copies of the TMEM199 gene, one from each biological parent. The genetic causes of TMEM199-CDG are usually passed down in an autosomal recessive pattern, so parents often do not know they are carriers. Carrying a genetic change doesn’t guarantee the condition will appear, because people with one changed copy are usually healthy carriers.
TMEM199 changes: TMEM199-CDG is caused by disease-causing changes in both copies of the TMEM199 gene. When both copies are affected, the body has trouble with glycosylation, a process cells use to prepare many proteins so they can work properly.
Recessive inheritance: TMEM199-CDG follows an autosomal recessive inheritance pattern. This means the condition usually appears only when one changed TMEM199 copy is inherited from each parent.
Carrier parents: If both biological parents carry one changed TMEM199 gene, each pregnancy has a 1 in 4, or 25%, chance of resulting in a child with TMEM199-CDG. In the same pregnancy, there is a 1 in 2, or 50%, chance the child will be an unaffected carrier.
Family history: A known family history of TMEM199-CDG increases the chance that close relatives may also carry the same gene change. This is especially relevant for brothers, sisters, and future pregnancies in the same family.
Related parents: When biological parents are related by blood, they are more likely to carry the same rare TMEM199 gene change. That raises the chance of recessive conditions such as TMEM199-CDG in their children.
Lifestyle risk factors
TMEM199-CDG is an inherited condition, so lifestyle habits do not cause it. Even so, how lifestyle affects TMEM199-CDG can matter because this disorder often involves the liver, blood fats, growth, and overall energy balance. Daily habits are mainly important for reducing extra stress on affected organs and helping symptoms stay as stable as possible. Because this condition is rare, lifestyle plans should be individualized with the treating metabolic and liver team.
Alcohol can add further strain to a liver already affected by TMEM199-CDG. Avoiding or strictly limiting alcohol may help reduce the risk of worsening liver inflammation, scarring, or abnormal liver tests.
Poor intake, crash dieting, or highly unbalanced eating patterns can make fatigue, poor growth, or metabolic stress harder to manage in TMEM199-CDG. Regular meals with enough calories, protein, vitamins, and minerals may better support liver function and day-to-day strength.
Frequent sugary drinks and excess refined carbohydrates can worsen high triglycerides or fatty liver problems that may occur in TMEM199-CDG. Choosing a steadier eating pattern with less added sugar may help limit extra metabolic burden.
Regular, moderate activity can support cardiovascular fitness, muscle strength, and lipid control in people living with TMEM199-CDG. Overexertion should be avoided if it triggers unusual fatigue, weakness, or poor recovery, especially when liver disease is significant.
Risk prevention
Tmem199-cdg is a rare inherited condition, so there is no known way to prevent the condition itself if someone is born with it. Prevention usually means lowering the risk of complications, especially liver problems, growth and nutrition issues, and infections, while helping day-to-day health stay as steady as possible. Different people need different prevention strategies—there’s no single formula.
Ongoing care with a metabolic or liver specialist can help catch changes early, before they become bigger problems. This often includes blood tests, growth checks, and scans when needed to watch how Tmem199-cdg is affecting the body.
Avoiding alcohol and being careful with medicines that can strain the liver may help reduce extra stress on an already vulnerable liver. Vaccination against hepatitis A and hepatitis B may also be recommended if a doctor advises it.
Steady nutrition can support growth, energy, and liver health in people with Tmem199-cdg. If eating is difficult, a dietitian may help with meal planning, supplements, or other ways to prevent poor weight gain.
Infections can make many inherited metabolic conditions harder to manage, so handwashing, routine vaccines, and prompt treatment of illness matter. This can be especially important if early symptoms of Tmem199-cdg include poor growth or low energy, since illness may worsen both.
Can you prevent Tmem199-cdg?
No, TMEM199-CDG cannot currently be prevented, because it is a rare inherited condition caused by a gene change that is present from the start of life. If this condition runs in your family, genetic counseling before pregnancy may help you understand the chance of passing it on and learn about available testing options.
Transmission
Tmem199-cdg is a genetic condition, not an infection, so it cannot spread from person to person through touch, coughing, sex, food, or everyday contact. When people ask how Tmem199-cdg is inherited, the usual pattern is that a child receives one changed copy of the gene from each parent.
This means the genetic transmission of Tmem199-cdg is typically autosomal recessive: parents are often healthy carriers and may not know they carry the change. If both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance that the baby will have Tmem199-cdg.
When to test your genes
Because TMEM199-CDG is inherited and usually begins in childhood, genetic testing is most useful when unexplained liver disease, abnormal liver tests, high cholesterol, or signs of cirrhosis appear, especially with a family history. A confirmed result can guide liver monitoring, family testing, and reproductive counseling.
Diagnosis
TMEM199-CDG is usually diagnosed when ongoing liver-related problems or other unusual findings lead doctors to look for a rare inherited cause. In many living with TMEM199-CDG, the diagnosis starts with a pattern rather than one single symptom, such as abnormal liver blood tests, fatty liver, or changes seen on a scan. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of TMEM199-CDG is then confirmed with specialized blood testing and a DNA test.
Doctors usually begin with symptoms, growth and development, and any past liver concerns. A detailed family and health history can help show whether the pattern fits a condition that may run in families.
Blood tests often show ongoing liver injury, and imaging findings may reveal an enlarged or fatty liver. These results do not prove TMEM199-CDG on their own, but they help point doctors toward a more specific workup.
Specialized blood tests can check whether certain proteins are being processed abnormally, which is a key clue in congenital disorders of glycosylation. This is often an important step in the diagnosis of TMEM199-CDG.
A genetic test looks for disease-causing changes in the TMEM199 gene. Finding changes in both copies of the gene confirms the diagnosis in most cases.
How is Tmem199-cdg diagnosed?
Doctors usually suspect TMEM199-CDG when someone has a pattern of ongoing liver problems, such as fatty liver or liver scarring, along with unusual blood test results. A key step is a special blood test that checks whether the body is attaching sugar tags to certain proteins in the usual way, because this condition affects that process. Genetic testing is then used to confirm the diagnosis by looking for a change in the TMEM199 gene, and some people also have liver scans or, less often, a liver biopsy to see how much the liver has been affected.
Stages of Tmem199-cdg
Tmem199-cdg does not have defined progression stages. This is because it is a rare inherited condition that is identified by its pattern of symptoms and test results, rather than by a clear step-by-step worsening that happens in the same way for everyone. Doctors usually start with a conversation about early symptoms of Tmem199-cdg, then check for signs such as liver problems, growth concerns, or developmental differences, along with blood tests and imaging when needed. Diagnosis is usually confirmed with genetic testing, and follow-up focuses on monitoring the liver and other affected body systems over time.
Outlook and prognosis
The outlook for people with TMEM199-CDG is still uncertain because only a small number of affected individuals have been reported, but the course often appears to be dominated by chronic liver disease rather than rapid neurologic decline. Some patients remain relatively stable for years, especially when developmental issues are mild or absent, while others develop progressive steatosis, fibrosis, cirrhosis, and portal hypertension. Published cases suggest that survival into adolescence or adulthood is possible, but long-term prognosis depends largely on how severe the liver involvement becomes and whether complications can be managed. In people with advanced liver disease, liver transplantation may be considered and can improve the outlook when medical therapy is not enough. Reliable mortality estimates are not available, but the main life-threatening risks are expected to come from complications of progressive liver failure rather than from a uniform, early-fatal disease course.
Long-term effects
For many living with TMEM199-CDG, the long-term picture is shaped most by liver disease, although the pattern can vary a lot from one person to another. Some people have relatively stable findings for years, while others develop more serious liver scarring over time. Long-term effects vary widely, and doctors usually look at growth, development, cholesterol levels, and liver function together when thinking about prognosis.
Ongoing liver inflammation and fat buildup are among the best-known long-term effects of TMEM199-CDG. Over time, this can lead to scarring, also called fibrosis, and in some people it may progress to cirrhosis.
When liver scarring becomes advanced, pressure can build up in the vein system that flows through the liver. This may enlarge the spleen and raise the risk of related complications such as low blood counts or enlarged veins in the food pipe.
Many people with TMEM199-CDG have long-term changes in blood fats, including high cholesterol. These lab changes can persist over time and often travel alongside the liver problems rather than appearing on their own.
Some children with TMEM199-CDG grow more slowly than expected or remain smaller than average. This may become clearer over the years, especially when liver disease is more pronounced.
How is it to live with Tmem199-cdg?
Living with TMEM199-CDG can look very different from one person to another, but for many it means ongoing monitoring for liver problems, fatigue, slower growth or development, and sometimes learning or movement challenges that can shape school, work, meals, and daily routines. Because this is a rare inherited condition, care often involves regular visits with specialists, blood tests, and extra attention to nutrition and energy, so daily life may need more planning than expected. Families and other close supporters are often deeply involved too, helping with appointments, treatments, and emotional support, while also learning to adjust to the uncertainty that can come with a condition that varies so much from person to person.
Treatment and drugs
Tmem199-cdg is treated mainly with supportive care, because there is no cure yet that fixes the underlying genetic change. Treatment often looks different for each person, but it usually focuses on the problems this condition can cause, especially liver disease, growth or feeding concerns, and any delays in development. Many people living with Tmem199-cdg need regular follow-up with specialists, blood tests, and treatment for complications, which may include nutrition support, vitamins if needed, and medicines to manage symptoms or related liver problems. If early symptoms of Tmem199-cdg are getting worse, your doctor may also recommend physical, occupational, or speech therapy, and in severe liver disease some may need care from a transplant team.
Can you cure Tmem199-cdg?
No, there is no cure for TMEM199-CDG at this time. Treatment cannot fix the genetic cause, but it can help manage the problems the condition can bring, especially liver issues and other symptoms. For many living with TMEM199-CDG, care means regular checkups and treatment to support day-to-day health and catch problems early.
Non-drug treatment
Living with Tmem199-cdg often means dealing with more than one issue at the same time, such as liver problems, low muscle tone, delayed development, or trouble with balance and movement. Managing this condition often involves supportive care from several specialists, tailored to the symptoms each person has. There is no single non-drug treatment that fits everyone, but therapies can help with comfort, daily function, growth, and development. Because this is a rare condition, supportive care for Tmem199-cdg is usually adjusted over time as needs change.
Regular follow-up with a metabolic or genetics team helps bring the different parts of care together. This can make it easier to track development, liver health, nutrition, and day-to-day needs.
Physical therapy can help build strength, improve balance, and support motor skills such as sitting, walking, or climbing stairs. For many, treatment begins not at the pharmacy, but with guided practice that makes everyday movement safer and easier.
Occupational therapy focuses on daily tasks like dressing, eating, handwriting, and using the hands well. Some may find it especially helpful when low muscle tone or coordination problems make routines tiring.
Speech and language therapy can help with communication, understanding, and, in some cases, feeding skills. If speech is limited, therapists may also suggest other ways to communicate, such as picture systems or devices.
Your genes may have an impact on how drugs work for you
For people living with TMEM199-CDG, there are no well-established gene-based rules showing that common medicines work differently in a predictable way just because of this condition. Still, because this condition often affects the liver, some medicines may stay in the body longer or cause more side effects, so a dose that seems ordinary for someone else may not feel ordinary here. In day-to-day care, this usually means doctors choose medicines carefully, start low when needed, and keep a closer eye on blood tests and side effects, especially with treatments that the liver has to process.
Pharmacological treatments
For many living with Tmem199-cdg, there is no medicine that corrects the underlying gene change, so treatment is usually aimed at the problems it causes, especially liver-related issues and abnormal blood fats. This means the drug plan can look different from one person to another, depending on age, symptoms, and how the liver is functioning. Not everyone responds to the same medication in the same way.
There is currently no approved disease-specific medication for Tmem199-cdg itself. In practice, treatment for Tmem199-cdg usually focuses on managing complications rather than reversing the condition.
If blood cholesterol or triglycerides are high, doctors may consider cholesterol-lowering medicines such as statins, depending on liver tests and the overall risk-benefit balance. These drugs do not treat the genetic cause, but they may help lower harmful blood fat levels in some people with Tmem199-cdg.
When advanced liver disease leads to problems such as fluid buildup in the abdomen, medicines like spironolactone and furosemide may be used. If portal hypertension is present, some people may also be prescribed a nonselective beta blocker such as propranolol to lower the risk of bleeding from enlarged veins.
If liver disease causes poor absorption or deficiency, doctors may prescribe vitamin supplements, including fat-soluble vitamins, as part of medical treatment. These are used to support nutrition and prevent complications, based on blood tests and individual needs.
Genetic influences
For many living with TMEM199-CDG, the key cause is genetic: this condition happens when both copies of the TMEM199 gene are not working properly. This gene helps cells handle and modify proteins, so when it is altered, several body systems can be affected, especially the liver. TMEM199-CDG is inherited in an autosomal recessive pattern, which means a child usually receives one changed copy of the gene from each parent. A carrier means you hold the gene change but may not show symptoms. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with TMEM199-CDG, a 50% chance of a child being a carrier, and a 25% chance of a child inheriting neither changed copy. Genetic testing can confirm the diagnosis and help families understand who else may be at risk.
Is Tmem199-cdg genetic?
Genetics are central to Tmem199-cdg because it is caused by changes in both copies of the TMEM199 gene, usually inherited from each parent. Different genetic changes can affect how severe Tmem199-cdg is and which problems appear first.
Having a genetic risk is not necessarily a diagnosis
Gene changes are a normal part of human biology and are common across the general population. Most of these changes do not directly affect health and simply make up part of natural human diversity. For many genes, carrying a change linked to a condition suggests a possible association rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood change in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Tmem199-cdg, the gene change is not just a background factor; it is the main reason the condition happens, so the genetic result can directly shape treatment decisions. Right now, there is no approved medicine that corrects the underlying TMEM199 change itself, so treatment for Tmem199-cdg usually focuses on the problems it causes, especially liver-related issues and other day-to-day symptoms. The exact variant and how severe the condition is can help doctors decide how closely to monitor the liver, growth, nutrition, development, and other complications, rather than relying on a one-size-fits-all plan. Genetics is only one factor, but in Tmem199-cdg it can help explain why one child may have milder symptoms while another needs more intensive follow-up. Genetic testing for Tmem199-cdg can also help avoid unnecessary treatments by showing that symptoms come from this rare inherited disorder and not from a different liver or metabolic disease. As research moves forward, the genetic diagnosis may also help families find specialists, join studies, and learn whether future targeted treatments might be relevant.
Interactions with other conditions
For many living with Tmem199-cdg, the main day-to-day health issues center on the liver, so other liver problems can have an outsized effect. Doctors call it a comorbidity when two conditions occur together. If someone with Tmem199-cdg also has a more common cause of liver injury, such as viral hepatitis, heavy alcohol use, or metabolic dysfunction-associated fatty liver disease, liver test abnormalities and scarring may become harder to sort out and may be more severe. Tmem199-cdg can also look similar to Wilson disease in some people because both can involve unusual copper-related lab results and ongoing liver disease, so careful testing is important. In children and adults with Tmem199-cdg, high blood fats may overlap with other metabolic conditions, which can add to the risk of fatty liver. Because this disorder is rare and the early symptoms of Tmem199-cdg can resemble more common liver diseases, coordinated care with a liver specialist and genetics team is often helpful.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Tmem199-cdg?
Because TMEM199-CDG often causes liver problems, poor growth, and delays in development, it can be mistaken for fatty liver disease, Wilson disease, mitochondrial disease, or other rare inherited metabolic conditions that affect the liver. Doctors may also compare it with other CDG conditions, which are related rare disorders that can cause similar liver test changes and developmental concerns.
History
For many living with Tmem199-cdg, the story often begins with symptoms that seem to point in different directions at once, such as ongoing liver problems, unusual blood test results, or slower growth in childhood. That is part of why this condition took time to recognize. Early reports described small numbers of people who shared a similar pattern of health issues, but doctors did not yet have a clear way to connect those findings into one diagnosis.
As testing methods improved, especially for rare metabolic conditions, researchers began to see that these scattered case reports were part of the same disorder. In recent decades, awareness has grown as specialists learned more about congenital disorders of glycosylation, a group of conditions that affect how the body processes and attaches sugars to proteins. This helped place Tmem199-cdg into a broader medical picture, rather than treating each symptom, such as liver disease or changes in cholesterol levels, as an unrelated problem.
The history of Tmem199-cdg is also a good example of how rare conditions are often understood step by step. First, doctors notice a repeating pattern. Later, laboratory testing and research make that pattern clearer, and researchers may identify a genetic cause behind it. For families, this can mean that what once felt like a long list of unexplained problems may finally receive a name.
Because Tmem199-cdg is so rare, its history is still fairly recent and continues to develop. Many of the details doctors now use to recognize the condition, including the early symptoms of Tmem199-cdg, have come from careful follow-up of a small number of affected people over time. That means the medical understanding is still growing, but the overall picture is much clearer today than it was when the first cases were described.